Advisory Boards

 

ViewRay draws on experience of industry leaders


ViewRay Vision

 

In this four-minute video, members of ViewRay's Scientific and Clinical Advisory Boards talk about the need for—and the potential of—the MRIdian system. "We believe this could be a paradigm changer in our field," says Sasa Mutic, PhD, professor of radiation oncology at Washington University.

Board of Directors

  Chris A. Raanes, ViewRay Incorporated

James Dempsey, PhD, ViewRay Incorporated

Josh Bilenker, MD, Aisling Capital

David Bonita, MD, OrbiMed Advisors

Caley Castelein, MD, Kearny Venture Partners

Mark Gold, MD, University of Florida College of Medicine

Henry A. McKinnell, Jr., Ph.D, Moody's Corporation and Accordia of Global Health Foundation

Aditya Puri, Xeraya Capital

Brian K. Roberts, Avedro

 

Scientific Advisory Board

John Bayouth, PhD, University of Wisconsin, Madison

Jeffrey Bradley, MD, Washington University, St. Louis, Missouri

David Larson, MD, PhD, University of California, San Francisco 

Bhudatt Paliwal, PhD, University of Wisconsin, Madison

Carlos A. Perez, MD, Washington University, St. Louis, Missouri 

Theodore L. Phillips, MD, University of California, San Francisco; University of California, Davis; University of Arizona, Tucson

James A. Purdy, PhD, University of California, Davis

Christopher M. Rose, MD, Valley Radiotherapy Associates Medical Group, Beverly Hills, California

Ben Slotman, MD, VU University Medical Center, Amsterdam

Michael Steinberg, MD, University of California, Los Angeles

Vincenzo Valentini, MD, Universita Cattolica S. Cuore Roma                         

Hong-Gyun Wu, MD, Seoul National University Hospital, Seoul, South Korea

 

Clinical trials Advisory Board

Minesh Mehta, MD, Northwestern University, Chicago, Illinois

William Mendenhall, MD, University of Florida, Gainesville

Copyright 2016 © ViewRay. All rights reserved - KMCreative